Adam Maeder
Stock Analyst at Piper Sandler
(4.53)
# 973
Out of 4,345 analysts
344
Total ratings
53%
Success rate
10.7%
Average return
Main Sectors:
Stocks Rated by Adam Maeder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GKOS Glaukos | Reiterated: Buy | $165 | $109.88 | +50.16% | 15 | May 22, 2026 | |
| STAA STAAR Surgical Company | Maintained: Hold | $16 → $33 | $31.39 | +5.13% | 5 | May 14, 2026 | |
| ISRG Intuitive Surgical | Reiterated: Buy | $580 | $418.55 | +38.57% | 48 | May 13, 2026 | |
| STXS Stereotaxis | Reiterated: Buy | $4 → $3.5 | $2.01 | +74.13% | 18 | May 13, 2026 | |
| NYXH Nyxoah | Reiterated: Buy | $9 → $7 | $2.82 | +148.23% | 24 | May 13, 2026 | |
| SGHT Sight Sciences | Reiterated: Buy | $9 | $4.87 | +84.80% | 8 | May 7, 2026 | |
| RXST RxSight | Maintained: Hold | $10 | $5.62 | +77.94% | 8 | May 7, 2026 | |
| RMD ResMed | Maintained: Hold | $275 → $233 | $206.10 | +13.05% | 7 | May 6, 2026 | |
| EW Edwards Lifesciences | Maintained: Buy | $100 | $86.51 | +15.59% | 55 | May 5, 2026 | |
| TCMD Tactile Systems Technology | Reiterated: Buy | $42 | $25.07 | +67.53% | 25 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $85 → $55 | $42.22 | +30.27% | 49 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $135 → $115 | $85.68 | +34.22% | 16 | Apr 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5.5 → $3 | $1.22 | +145.90% | 13 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 | $73.90 | +15.02% | 32 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8.5 → $7 | $0.96 | +629.17% | 12 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $0.8795 | +354.80% | 6 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $74 | $32.95 | n/a | 1 | Apr 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.45 → $2.07 | $0.275 | n/a | 2 | Dec 23, 2019 |
Glaukos
May 22, 2026
Reiterated: Buy
Price Target: $165
Current: $109.88
Upside: +50.16%
STAAR Surgical Company
May 14, 2026
Maintained: Hold
Price Target: $16 → $33
Current: $31.39
Upside: +5.13%
Intuitive Surgical
May 13, 2026
Reiterated: Buy
Price Target: $580
Current: $418.55
Upside: +38.57%
Stereotaxis
May 13, 2026
Reiterated: Buy
Price Target: $4 → $3.5
Current: $2.01
Upside: +74.13%
Nyxoah
May 13, 2026
Reiterated: Buy
Price Target: $9 → $7
Current: $2.82
Upside: +148.23%
Sight Sciences
May 7, 2026
Reiterated: Buy
Price Target: $9
Current: $4.87
Upside: +84.80%
RxSight
May 7, 2026
Maintained: Hold
Price Target: $10
Current: $5.62
Upside: +77.94%
ResMed
May 6, 2026
Maintained: Hold
Price Target: $275 → $233
Current: $206.10
Upside: +13.05%
Edwards Lifesciences
May 5, 2026
Maintained: Buy
Price Target: $100
Current: $86.51
Upside: +15.59%
Tactile Systems Technology
May 5, 2026
Reiterated: Buy
Price Target: $42
Current: $25.07
Upside: +67.53%
May 5, 2026
Downgraded: Hold
Price Target: $85 → $55
Current: $42.22
Upside: +30.27%
Apr 17, 2026
Maintained: Buy
Price Target: $135 → $115
Current: $85.68
Upside: +34.22%
Apr 7, 2026
Maintained: Buy
Price Target: $5.5 → $3
Current: $1.22
Upside: +145.90%
Feb 19, 2026
Reiterated: Buy
Price Target: $85
Current: $73.90
Upside: +15.02%
Aug 13, 2025
Maintained: Hold
Price Target: $8.5 → $7
Current: $0.96
Upside: +629.17%
Aug 1, 2025
Maintained: Buy
Price Target: $4
Current: $0.8795
Upside: +354.80%
Apr 9, 2020
Initiated Coverage: Buy
Price Target: $74
Current: $32.95
Upside: n/a
Dec 23, 2019
Reiterated: Buy
Price Target: $3.45 → $2.07
Current: $0.275
Upside: n/a